We downgrade HI-P INTERNATIONAL LIMITED (SGX:H17) to SELL from HOLD and cut our ROE-g/COE-g Target Price to SGD0.68. We:
cut FY18-20E EPS by 2-4% after its biggest customer revised its revenue guidance downwards, and
increase our COE assumption from 9% to 10.3% for increased volatility in the stock.
De-rating catalysts are expected from:
pricing pressure,
relocation costs in 2019, and
a potential material deterioration in global consumer sentiment.
We prefer VENTURE CORPORATION LIMITED (SGX:V03) and VALUETRONICS HOLDINGS LIMITED (SGX:BN2) for sector exposure. Risks to our view include a strong rebound in volumes that could alleviate pricing pressure.
Vulnerable to Consumer Sentiment Downturn
Our earnings cuts mainly reflect lower revenue guidance from Hi-P’s largest customer, which accounts for 40-50% of its revenue. This customer has cited unexpected weakness in Greater China and believes the US-China trade war is partly to blame.
We believe Hi-P’s revenue mix makes it vulnerable to a material decline in global consumer sentiment. We estimate that 80% of its revenue comes from consumer discretionary electronic products and that at least 30-40% has short life cycles of 1-3 years.
Margin Pressure
Pricing pressure could persist as volumes remain weak. Economies of scale could also drop as it diversifies its product mix amid weaker volumes.
Lastly, Hi-P will be incurring one-off costs for a relocation of its resources to its Thailand and Nantong facilities.
Earnings Revisions
We shave FY18-20E earnings by 2-4% following cuts in sales guidance by Hi-P’s largest customer, which we estimate account for 40-50% of its revenue. The customer has cited unexpected weakness in Greater China, which it believes was partly caused by the US-China trade war.
We estimate that 80% of Hi-P’s revenue comes from consumer discretionary electronic products. At least 30-40% is products with short life cycles of 1-3 years. In our view, this makes Hi-P vulnerable to a downswing in consumer sentiment globally.
Valuation
Our ROE-g/COE-g Target Price is now based on 0.8x FY19E P/BV, from 1x previously. We increase our beta assumption from 1x to 1.2x to factor in increased volatility of the stock.
Our Target Price implies 9x FY19E P/E, in line with global EMS peers’ 8.4x average.
A key risk to our call is a strong rebound in volumes.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....